EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $88,000 | -12.0% | 177,127 | -1.8% | 0.00% | – |
Q4 2021 | $100,000 | -56.1% | 180,331 | +2.7% | 0.00% | – |
Q3 2021 | $228,000 | +3.2% | 175,559 | +9.2% | 0.00% | – |
Q2 2021 | $221,000 | -19.9% | 160,770 | +6.5% | 0.00% | – |
Q1 2021 | $276,000 | -23.3% | 150,891 | +8.2% | 0.00% | – |
Q4 2020 | $360,000 | -40.1% | 139,474 | +8.7% | 0.00% | – |
Q3 2020 | $601,000 | -14.9% | 128,275 | -35.7% | 0.00% | – |
Q2 2020 | $706,000 | +908.6% | 199,428 | +229.5% | 0.00% | – |
Q1 2020 | $70,000 | -23.1% | 60,532 | +8.1% | 0.00% | – |
Q4 2019 | $91,000 | +93.6% | 55,972 | +1.9% | 0.00% | – |
Q3 2019 | $47,000 | +46.9% | 54,940 | +6.4% | 0.00% | – |
Q2 2019 | $32,000 | -74.8% | 51,636 | -39.1% | 0.00% | – |
Q1 2019 | $127,000 | -38.6% | 84,741 | +1.4% | 0.00% | – |
Q4 2018 | $207,000 | -12.3% | 83,583 | +5.5% | 0.00% | – |
Q3 2018 | $236,000 | +23.6% | 79,191 | +3.8% | 0.00% | – |
Q2 2018 | $191,000 | +38.4% | 76,288 | +15.5% | 0.00% | – |
Q1 2018 | $138,000 | -6.8% | 66,078 | +0.8% | 0.00% | – |
Q4 2017 | $148,000 | -29.2% | 65,529 | +5.1% | 0.00% | – |
Q3 2017 | $209,000 | +34.0% | 62,369 | +2.4% | 0.00% | – |
Q2 2017 | $156,000 | +20.0% | 60,926 | +45.7% | 0.00% | – |
Q1 2017 | $130,000 | – | 41,803 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 87,925 | $48,000 | 0.01% |
Wambolt & Associates, LLC | 32,000 | $18,000 | 0.01% |
Virtu Financial LLC | 55,336 | $31,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 183 | $0 | 0.00% |
NORTHERN TRUST CORP | 42,121 | $23,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 3,828 | $2,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 210,102 | $117,000 | 0.00% |
STATE STREET CORP | 72,800 | $41,000 | 0.00% |
MORGAN STANLEY | 9,606 | $5,000 | 0.00% |